An open-label analyze was performed in 2016 in the UK to analyze the feasibility, safety and efficacy of psilocybin in treating clients with unipolar treatment-resistant depression with promising success; Even though the research was tiny and concerned only twelve individuals, seven of those people satisfied formal conditions for remission a person… Read More